About
Stef Verlinden is a Dutch medical doctor, entrepreneur, and aging researcher focused on healthspan extension. He is the founder, CEO, and Chief Innovation Officer of YOXLO, where he leads scientific strategy around interventions targeting aging biology. Earlier public references tie him to HLXTH and Vivici, reflecting a longer track record in nutraceutical, preventive-health, and digital-health ventures.
Areas of interest
longevityhealthy agingbiotechgeroscienceclinical researchnutraceuticalsmitochondrial functioncellular dysfunctioninflammationNLRP3cognitionmuscle agingimmune agingdigital health